Are Discount Rates Too High? Population Health and Intergenerational Equity

Med Decis Making. 2021 Feb;41(2):245-249. doi: 10.1177/0272989X20979816. Epub 2021 Jan 13.

Abstract

Increasing attention is being paid to policy decisions in which shorter-term benefits may be eclipsed by longer-term harms, such as environmental damage. Health policy decisions have largely been spared this scrutiny, even though they too may contribute to longer-term harms. Any healthy population or society must sustain itself through reproduction, and therefore, transgenerational outcomes should be of intrinsic importance from a societal perspective. Yet, the discount rates typically employed in cost-effectiveness analyses have the effect of minimizing the importance of transgenerational health outcomes. We argue that, because cost-effectiveness analysis is based on foundational axioms of decision theory, it should value transgenerational outcomes consistently with those axioms, which require discount rates substantially lower than 3%. We discuss why such lower rates may not violate the Cretin-Keeler paradox.

Keywords: cost-effectiveness analysis; discount rate; equity; time preference.

MeSH terms

  • Cost-Benefit Analysis
  • Health Status*
  • Humans
  • Population Health*